Yield10 Bioscience, Inc. (YTEN) Tops Q4 EPS by 2c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q4 EPS of ($0.61), $0.02 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $152 thousand versus the consensus estimate of $100 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• SanDisk upgraded at JPMorgan after investor day; shares climb